ArticlePCN reports : psychiatry and clinical neurosciences2023

A multicenter, double-blind, randomized, controlled study of patients with treatment-resistant schizophrenia treated with yokukansan for 12 weeks.

Jun Horiguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.